ANIK Buybacks
12 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–12; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Anika Therapeutics, Inc. | 2026-03-31 | Reported repurchase cash | $8.69M |
| Anika Therapeutics, Inc. | 2025-12-31 | Reported repurchase cash | $5.51M |
| Anika Therapeutics, Inc. | 2025-03-31 | Reported repurchase cash | $3.97M |
| Anika Therapeutics, Inc. | 2024-12-31 | Reported repurchase cash | $5.58M |
| Anika Therapeutics, Inc. | 2024-03-31 | Reported repurchase cash | $0.00 |
| Anika Therapeutics, Inc. | 2023-12-31 | Reported repurchase cash | $0.00 |
| Anika Therapeutics, Inc. | 2022-12-31 | Reported repurchase cash | $0.00 |
| Anika Therapeutics, Inc. | 2020-12-31 | Reported repurchase cash | $0.00 |
| Anika Therapeutics, Inc. | 2019-12-31 | Reported repurchase cash | $0.00 |
| Anika Therapeutics, Inc. | 2018-12-31 | Reported repurchase cash | $0.00 |
| Anika Therapeutics, Inc. | 2016-12-31 | Reported repurchase cash | $0.00 |
| Anika Therapeutics, Inc. | 2016-03-31 | Reported repurchase cash | $25M |